This session will explore the genetic and biochemical pathways that contribute to HIV drug resistance. Emphasis will be placed on recent discoveries that enhance our understanding of resistance mechanisms at the molecular level.

This track will focus on the latest advancements in molecular diagnostics for HIV detection and drug resistance testing. Participants will discuss the implications of these innovations for early intervention and patient management.

This session will address the design and implementation of clinical trials aimed at evaluating new therapeutic interventions for HIV. Key challenges and opportunities in recruiting diverse populations and measuring outcomes will be highlighted.

This track will examine current and emerging therapeutic strategies for managing HIV infection and drug resistance. Discussions will include combination therapies, novel drug classes, and personalized medicine approaches.

This session will focus on the importance of patient-centered care in the management of HIV and drug resistance. Strategies to enhance treatment adherence and improve health outcomes will be critically analyzed.

This track will showcase cutting-edge laboratory techniques and technologies that are advancing HIV research. Topics will include high-throughput screening, next-generation sequencing, and bioinformatics applications.